D-0651-2017 Class III Terminated

Recalled by West-Ward Columbus, Inc. — Columbus, OH

FDA drug recall D-0651-2017 was initiated by West-Ward Columbus, Inc. on Apr 4, 2017 and is designated Class III. Reason for recall: Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print. The recall status is terminated (terminated Sep 4, 2018). Affected quantity: 100 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 19, 2017
Initiation Date
Apr 4, 2017
Termination Date
Sep 4, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
100 bottles

Product description

Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ -- NDC 0054-0338-19

Reason for recall

Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.

Distribution pattern

The recalled product was distributed to the following state: OH. There are no Canada accounts for this recall. There are no Mexico accounts for this recall. There are no government accounts for this recall.

Code information

Lot KB60707, 10/31/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0651-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0651-2017. Report a data issue: hello@regdatalab.com.